Patent details

Basic Information

Publication number:

EP3554474

PCT Application Number:

US2017066652

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178294120

PCT Publication Number:

WO2018112330

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MICAFUNGIN COMPOSITIONS

French Title of Invention:

COMPOSITIONS DE MICAFUNGINE

German Title of Invention:

MICAFUNGIN-ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

15/12/2017

Grant date:

06/12/2023

EP Publication Date:

23/10/2019

PCT Publication Date:

21/06/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/12/2023

EP B1 Publication Date:

06/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/12/2023

Expiration date:

15/12/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/11/2023

 

 

Name:

Baxter Healthcare SA

Address:

Thurgauerstrasse 130, 8152 Glattpark (Opfikon), Switzerland (CH)

Name:

Baxter International Inc.

Address:

One Baxter Parkway, Deerfield, IL 60015, United States (US)

Inventor

1

Name:

DOTY, Mark J.

Address:

United States (US)

2

Name:

REBBECK, Christine L.

Address:

United States (US)

3

Name:

COPE, Sydney J.

Address:

United States (US)

Priority

Priority Number:

201662435695 P

Priority Date:

16/12/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 31/375;

Publication

European Patent Bulletin

Issue number:

202349

Publication date:

06/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages